Figure 6.
Anti-GITR IgG2a depletes Tregs at the tumor site and promotes abscopal effects when combined with radiation and anti-PD1, while anti-GITR IgG1 expands Tregs and does not promote abscopal effects. (A) Flow cytometry percentages of CD4+ Foxp3+ T cells in gated lymphocytes isolated from tumors and spleens, 6 days post XRT. (n = 6) (B) Primary and (C) secondary tumors were inoculated and XRT was delivered 10 days post tumor inoculation (n = 6). (D) Survival was monitored out to day 63 (n = 6). *P ≤ 0.05 in Student t-tests.